Literature DB >> 10364495

Novel expression of mouse adenovirus type 1 early region 3 gp11K at late times after infection.

A N Cauthen1, K R Spindler.   

Abstract

Mutations were introduced into mouse adenovirus type 1 (MAV-1) early region 3 (E3) initiator codons by homologous recombination between viral DNA and a plasmid containing a mutagenized E3 region. The resulting mutant virus, pmE312, contained ATG --> TTA mutations at codon positions 1 and 4 and was expected to be null for the expression of the E3 proteins. However, gp11K, an MAV-1 E3 glycoprotein of 14K molecular weight, was detected in mutant-infected cell lysates at levels about 10-12% of that of wild-type (wt) virus at late times in infection. The gp11K polypeptide produced by pmE312 at late times was immunoprecipitated with two E3-specific antisera prepared against different regions of the protein. Like gp11K produced by wt virus infections, it was sensitive to endoglycosidase H (endo H) and thus resident in the endoplasmic reticulum (ER). In pmE312-infected cells treated with cytosine arabinoside (araC), an inhibitor of DNA replication, the gp11K protein was not detected by immunoprecipitation. This indicates that gp11K expression in pmE312-infected cells at late times was dependent on DNA replication and that it was thus translated from a late transcript. In vitro translation of poly(A)+ RNA from mock-, wild-type-, and pmE312-infected cells showed that gp11K was translated from late mRNA as an approximately 28K fusion between a late protein and gp11K. Our data are consistent with a model in which gp11K is expressed at late times as a late protein-gp11K chimera in both wt- and mutant-infected cells. This chimera is then processed: removal of a large N-terminal sequence results in the observed 14K ER-localized gp11K. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364495     DOI: 10.1006/viro.1999.9713

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

1.  In vitro and in vivo characterization of a mouse adenovirus type 1 early region 3 null mutant.

Authors:  A N Cauthen; C C Brown; K R Spindler
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Mouse adenovirus type 1-induced breakdown of the blood-brain barrier.

Authors:  Lisa E Gralinski; Shanna L Ashley; Shandee D Dixon; Katherine R Spindler
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

3.  Biology of ovine adenovirus infection of nonpermissive cells.

Authors:  Daniel Kümin; Christian Hofmann; Michael Rudolph; Gerald W Both; Peter Löser
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.

Authors:  Michael Robinson; Betty Li; Ying Ge; Derek Ko; Satya Yendluri; Thomas Harding; Melinda VanRoey; Katherine R Spindler; Karin Jooss
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

5.  Enhanced Replication of Mouse Adenovirus Type 1 following Virus-Induced Degradation of Protein Kinase R (PKR).

Authors:  Danielle E Goodman; Carla D Pretto; Tomas A Krepostman; Kelly E Carnahan; Katherine R Spindler
Journal:  mBio       Date:  2019-04-23       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.